MedTrace Logo

Influence of Thoracic Paravertebral Block on Atrioventricular Conduction

NCT06833086 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2025-04-03

No results posted yet for this study

Summary

The aim of the study is to assess the changes in electrical activity of heart atria and in atrioventricular conduction induced by anaesthetic thoracic paravertebral blockade, depending on site on which blockade was performed.

Researchers will retrospectively compare ECG recordings of patients that undergone unilateral paravertebral blockade at T3 level with 0.5% ropivacaine. The investigation will include measurement of P wave and PR interval, and subsequent statystical analysis.

Conditions

  • Conduction Abnormalities
  • Paravertebral Anesthesia

Interventions

PROCEDURE

Paravertebral block (ropivacaine) left

Paravertebral block at the level of 3rd thoracic intervertebral space on the left side. 0.5% Ropivacaine 0.3 ml·kg-1, not exceeding 30 ml, based on ideal body weight in obese patients

PROCEDURE

Paravertebral block (ropivacaine) right

Paravertebral block at the level of 3rd thoracic intervertebral space on the right side. 0.5% Ropivacaine 0.3 ml·kg-1, not exceeding 30 ml, based on ideal body weight in obese patients

Sponsors & Collaborators

  • Medical University of Gdansk

    lead OTHER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-20
Primary Completion
2025-03-31
Completion
2025-03-31

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06833086 on ClinicalTrials.gov